BRAINSTORM CELL THERAPEUTICS INC.
BCLI
Transaktioner
136
Köp
122
Sälj
14
Nettoinsynsflöde
-246 k USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
136 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-07-24 | FRENKEL JACOB A | Director | Buy | 100 k | 0,00 | 0 USD |
| 2026-07-24 | FRENKEL JACOB A | Director | Buy | 100 k | 0,00 | 0 USD |
| 2026-02-26 | ARBEL IRIT | Director | Buy | 120 k | 0,00 | 0 USD |
| 2026-02-26 | ARBEL IRIT | Director | Buy | 120 k | 0,00 | 0 USD |
| 2026-02-26 | FRENKEL JACOB A | Director | Buy | 200 k | 0,00 | 0 USD |
| 2026-02-26 | Patlis Alla | See Remarks | Buy | 100 k | 0,00 | 0 USD |
| 2026-02-26 | Yablonka Uri | EVP & Chief Business Officer | Buy | 150 k | 0,00 | 0 USD |
| 2026-02-26 | Lebovits Chaim | President & CEO | Buy | 1.8 mn | 0,00 | 0 USD |
| 2026-02-26 | FRENKEL JACOB A | Director | Buy | 200 k | 0,00 | 0 USD |
| 2026-02-26 | Lebovits Chaim | President & CEO | Buy | 1.8 mn | 0,00 | 0 USD |
| 2026-02-26 | Patlis Alla | See Remarks | Buy | 100 k | 0,00 | 0 USD |
| 2026-02-26 | Yablonka Uri | EVP & Chief Business Officer | Buy | 150 k | 0,00 | 0 USD |
| 2025-01-01 | Dagher Ibrahim B. | Chief Medical Officer | Buy | 50 k | 0,00 | 0 USD |
| 2025-01-01 | Dagher Ibrahim B. | Chief Medical Officer | Buy | 50 k | 0,00 | 0 USD |
| 2025-01-01 | ARBEL IRIT | Director | Buy | 31 k | 0,00 | 0 USD |
| 2025-01-01 | ARBEL IRIT | Director | Buy | 31 k | 0,00 | 0 USD |
| 2025-01-01 | Bairu Menghisteab | Director | Buy | 24 k | 0,00 | 0 USD |
| 2025-01-01 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | Buy | 50 k | 0,00 | 0 USD |
| 2025-01-01 | Lindborg Stacy | Director | Buy | 20 k | 0,00 | 0 USD |
| 2025-01-01 | Naor Nir | Director | Buy | 31 k | 0,00 | 0 USD |
| 2025-01-01 | Patlis Alla | See Remarks | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-01 | Yablonka Uri | EVP & Chief Business Officer | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-01 | Yablonka Uri | EVP & Chief Business Officer | Buy | 20 k | 0,00 | 0 USD |
| 2025-01-01 | Polverino Anthony J. | Director | Buy | 24 k | 0,00 | 0 USD |
| 2025-01-01 | FRENKEL JACOB A | Director | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-01 | Lebovits Chaim | President & CEO | Buy | 120 k | 0,00 | 0 USD |
| 2025-01-01 | Bairu Menghisteab | Director | Buy | 24 k | 0,00 | 0 USD |
| 2025-01-01 | FRENKEL JACOB A | Director | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-01 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | Buy | 50 k | 0,00 | 0 USD |
| 2025-01-01 | Lebovits Chaim | President & CEO | Buy | 120 k | 0,00 | 0 USD |
| 2025-01-01 | Lindborg Stacy | Director | Buy | 20 k | 0,00 | 0 USD |
| 2025-01-01 | Naor Nir | Director | Buy | 31 k | 0,00 | 0 USD |
| 2025-01-01 | Patlis Alla | See Remarks | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-01 | Polverino Anthony J. | Director | Buy | 24 k | 0,00 | 0 USD |
| 2025-01-01 | Yablonka Uri | EVP & Chief Business Officer | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-01 | Yablonka Uri | EVP & Chief Business Officer | Buy | 20 k | 0,00 | 0 USD |
| 2024-10-01 | Lebovits Chaim | President & CEO | Buy | 2 k | 3,43 | 6 k USD |
| 2024-10-01 | Lebovits Chaim | President & CEO | Buy | 2 k | 3,43 | 6 k USD |
| 2024-09-30 | Lebovits Chaim | President & CEO | Buy | 22 k | 0,23 | 5 k USD |
| 2024-09-30 | Lebovits Chaim | President & CEO | Buy | 22 k | 0,23 | 5 k USD |
| 2024-07-19 | Dagher Ibrahim B. | Chief Medical Officer | Sell | 63 k | 0,35 | 22 k USD |
| 2024-07-19 | Dagher Ibrahim B. | Chief Medical Officer | Sell | 63 k | 0,35 | 22 k USD |
| 2024-06-24 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | Buy | 30 k | 0,00 | 0 USD |
| 2024-06-24 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | Buy | 30 k | 0,00 | 0 USD |
| 2024-05-28 | Lebovits Chaim | President & CEO | Buy | 15 k | 0,52 | 8 k USD |
| 2024-05-28 | Lebovits Chaim | President & CEO | Buy | 15 k | 0,52 | 8 k USD |
| 2024-05-22 | Lebovits Chaim | President & CEO | Buy | 25 k | 0,64 | 16 k USD |
| 2024-05-22 | Lebovits Chaim | President & CEO | Buy | 25 k | 0,64 | 16 k USD |
| 2024-05-21 | Lebovits Chaim | President & CEO | Buy | 25 k | 0,58 | 14 k USD |
| 2024-05-21 | Lebovits Chaim | President & CEO | Buy | 25 k | 0,58 | 14 k USD |
| 2024-05-13 | Lebovits Chaim | President & CEO | Buy | 10 k | 0,49 | 5 k USD |
| 2024-05-13 | Lebovits Chaim | President & CEO | Buy | 10 k | 0,49 | 5 k USD |
| 2024-05-11 | Lebovits Chaim | President & CEO | Buy | 10 k | 0,47 | 5 k USD |
| 2024-05-11 | Lebovits Chaim | President & CEO | Buy | 10 k | 0,47 | 5 k USD |
| 2024-05-10 | Lebovits Chaim | President & CEO | Buy | 20 k | 0,47 | 9 k USD |
| 2024-05-10 | Lebovits Chaim | President & CEO | Buy | 20 k | 0,47 | 9 k USD |
| 2024-05-07 | Lebovits Chaim | President & CEO | Buy | 66 k | 0,37 | 25 k USD |
| 2024-05-07 | Lebovits Chaim | President & CEO | Buy | 66 k | 0,37 | 25 k USD |
| 2024-05-06 | Lebovits Chaim | President & CEO | Buy | 135 k | 0,38 | 51 k USD |
| 2024-05-06 | Lebovits Chaim | President & CEO | Buy | 135 k | 0,38 | 51 k USD |
| 2024-04-19 | Lebovits Chaim | President & CEO | Buy | 15 k | 0,52 | 8 k USD |
| 2024-04-19 | Lebovits Chaim | President & CEO | Buy | 15 k | 0,52 | 8 k USD |
| 2024-04-18 | Lebovits Chaim | President & CEO | Buy | 115 k | 0,53 | 60 k USD |
| 2024-04-18 | Lebovits Chaim | President & CEO | Buy | 115 k | 0,53 | 60 k USD |
| 2024-04-17 | Lebovits Chaim | President & CEO | Buy | 130 k | 0,55 | 71 k USD |
| 2024-04-17 | Lebovits Chaim | President & CEO | Buy | 130 k | 0,55 | 71 k USD |
| 2024-03-11 | Lebovits Chaim | President & CEO | Buy | 305 k | 0,00 | 0 USD |
| 2024-03-11 | Patlis Alla | See Remarks | Buy | 65 k | 0,00 | 0 USD |
| 2024-03-11 | Yablonka Uri | EVP & Chief Business Officer | Buy | 109 k | 0,00 | 0 USD |
| 2024-03-11 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 242 k | 0,00 | 0 USD |
| 2024-03-11 | Lebovits Chaim | President & CEO | Buy | 305 k | 0,00 | 0 USD |
| 2024-03-11 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 242 k | 0,00 | 0 USD |
| 2024-03-11 | Patlis Alla | See Remarks | Buy | 65 k | 0,00 | 0 USD |
| 2024-03-11 | Yablonka Uri | EVP & Chief Business Officer | Buy | 109 k | 0,00 | 0 USD |
| 2023-09-01 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 12 k | 1,77 | 20 k USD |
| 2023-09-01 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 12 k | 1,77 | 20 k USD |
| 2023-08-02 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 35 k | 0,00 | 0 USD |
| 2023-08-02 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 35 k | 0,00 | 0 USD |
| 2023-08-02 | Lebovits Chaim | President & CEO | Buy | 31 k | 0,00 | 0 USD |
| 2023-08-02 | Lebovits Chaim | President & CEO | Buy | 31 k | 0,00 | 0 USD |
| 2023-06-19 | Naor Nir | Director | Buy | 12 k | 0,00 | 0 USD |
| 2023-06-19 | Naor Nir | Director | Buy | 12 k | 0,00 | 0 USD |
| 2023-05-01 | Taylor Kirk | Chief Medical Officer | Buy | 35 k | 0,00 | 0 USD |
| 2023-05-01 | Taylor Kirk | Chief Medical Officer | Buy | 35 k | 0,00 | 0 USD |
| 2023-04-20 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 75 k | 0,00 | 0 USD |
| 2023-04-20 | Lebovits Chaim | President & Co-CEO | Buy | 75 k | 0,00 | 0 USD |
| 2023-04-20 | Lebovits Chaim | President & Co-CEO | Buy | 75 k | 0,00 | 0 USD |
| 2023-04-20 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 75 k | 0,00 | 0 USD |
| 2022-12-07 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 35 k | 0,00 | 0 USD |
| 2022-12-07 | Lindborg Stacy | Co-Chief Executive Officer | Buy | 35 k | 0,00 | 0 USD |
| 2022-09-18 | Lebovits Chaim | Chief Executive Officer | Buy | 31 k | 0,00 | 0 USD |
| 2022-09-18 | Lebovits Chaim | Chief Executive Officer | Buy | 31 k | 0,00 | 0 USD |
| 2022-03-06 | Kern Ralph Dr. | COO and Chief Medical Officer | Buy | 36 k | 0,00 | 0 USD |
| 2022-03-06 | Kern Ralph Dr. | COO and Chief Medical Officer | Buy | 36 k | 0,00 | 0 USD |
| 2022-02-01 | Polverino Anthony J. | Director | Buy | 4 k | 0,00 | 0 USD |
| 2022-02-01 | Polverino Anthony J. | Director | Buy | 4 k | 0,00 | 0 USD |
| 2021-12-15 | Almenoff June Sherie | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-15 | Almenoff June Sherie | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-15 | Polverino Anthony J. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-15 | TAUB MALCOLM S | Director | Buy | 12 k | 0,00 | 0 USD |
| 2021-12-15 | Polverino Anthony J. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-15 | TAUB MALCOLM S | Director | Buy | 12 k | 0,00 | 0 USD |
| 2021-12-10 | Abbhi Sankesh | Director | Buy | 7 k | 0,00 | 0 USD |
| 2021-12-10 | Almenoff June Sherie | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-10 | Almenoff June Sherie | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-10 | Abbhi Sankesh | Director | Buy | 7 k | 0,00 | 0 USD |
| 2021-12-10 | Polverino Anthony J. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-10 | Polverino Anthony J. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-10 | TAUB MALCOLM S | Director | Buy | 12 k | 0,00 | 0 USD |
| 2021-12-10 | Lebovits Chaim | Chief Executive Officer | Buy | 31 k | 0,00 | 0 USD |
| 2021-12-10 | Kern Ralph Dr. | COO and Chief Medical Officer | Buy | 36 k | 0,00 | 0 USD |
| 2021-12-10 | Kern Ralph Dr. | COO and Chief Medical Officer | Buy | 36 k | 0,00 | 0 USD |
| 2021-12-10 | Lebovits Chaim | Chief Executive Officer | Buy | 31 k | 0,00 | 0 USD |
| 2021-12-10 | Polverino Anthony J. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-10 | Polverino Anthony J. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-10 | TAUB MALCOLM S | Director | Buy | 12 k | 0,00 | 0 USD |
| 2020-12-30 | Shah Preetam | EVP, CFO and Treasurer | Sell | 25 k | 4,64 | 116 k USD |
| 2020-12-30 | Shah Preetam | EVP, CFO and Treasurer | Sell | 25 k | 4,64 | 116 k USD |
| 2020-09-08 | Waclawski Anthony | See Remarks | Buy | 35 k | 0,00 | 0 USD |
| 2020-09-08 | Waclawski Anthony | See Remarks | Buy | 35 k | 0,00 | 0 USD |
| 2020-07-26 | Lebovits Chaim | Chief Executive Officer | Buy | 31 k | 0,00 | 0 USD |
| 2020-07-26 | Lebovits Chaim | Chief Executive Officer | Buy | 31 k | 0,00 | 0 USD |
| 2020-07-16 | ACC International Holdings Ltd. | – | Sell | 8 k | 13,47 | 105 k USD |
| 2020-07-16 | ACC International Holdings Ltd. | – | Sell | 8 k | 13,47 | 105 k USD |
| 2020-07-16 | Setboun David | EVP and COO | Buy | 5 k | 12,95 | 65 k USD |
| 2020-07-16 | Setboun David | EVP and COO | Buy | 5 k | 12,95 | 65 k USD |
| 2020-07-15 | ACC International Holdings Ltd. | – | Sell | 18 k | 13,12 | 242 k USD |
| 2020-07-15 | Abbhi Sankesh | Director | Buy | 47 k | 12,99 | 608 k USD |
| 2020-07-15 | ACC International Holdings Ltd. | – | Sell | 18 k | 13,12 | 242 k USD |
| 2020-07-15 | Abbhi Sankesh | Director | Buy | 47 k | 12,99 | 608 k USD |
| 2020-07-13 | ACC International Holdings Ltd. | – | Sell | 40 k | 13,52 | 541 k USD |
| 2020-07-13 | ACC International Holdings Ltd. | – | Sell | 40 k | 13,52 | 541 k USD |
| 2020-07-10 | ACC International Holdings Ltd. | – | Sell | 2 k | 13,35 | 27 k USD |
| 2020-07-10 | ACC International Holdings Ltd. | – | Sell | 2 k | 13,35 | 27 k USD |
| 2020-07-09 | ACC International Holdings Ltd. | – | Sell | 4 k | 13,13 | 46 k USD |
| 2020-07-09 | ACC International Holdings Ltd. | – | Sell | 4 k | 13,13 | 46 k USD |